Bicycle Therapeutics Breakout on Daily timeframe.
Hold the green line and up to target.
Weekly RSI + Stochastic bottomed
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−3.63 USD
−169.10 M USD
35.29 M USD
44.34 M
About Bicycle Therapeutics Plc Sponsored ADR
Sector
Industry
CEO
Kevin Lee
Website
Headquarters
Cambridge
Founded
2009
IPO date
May 23, 2019
IPO offer price
14.00 USD
Identifiers
3
ISINUS0887861088
Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. Its portfolio includes internal product candidates that are directed to oncology applications. The company was founded by Gregory Winter, John Tite, and Christian Heinis in 2009 and is headquartered in Cambridge, the United Kingdom.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
